Comment on “Trimorphs of a pharmaceutical cocrystal involving two active pharmaceutical ingredients: potential relevance to combination drugs” by S. Aitipamula, P. S. Chow and R. B. H. Tan, CrystEngComm, 2009, 11, 1823†,CrystEngComm

当前位置： X-MOL 学术 › CrystEngComm › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Comment on “Trimorphs of a pharmaceutical cocrystal involving two active pharmaceutical ingredients: potential relevance to combination drugs” by S. Aitipamula, P. S. Chow and R. B. H. Tan, CrystEngComm, 2009, 11, 1823†
CrystEngComm ( IF 3.1 ) Pub Date : 2017-12-13 00:00:00 , DOI: 10.1039/c7ce01448a
Łukasz Szeleszczuk _{1,

2,

3,

4,

5} , Dariusz Maciej Pisklak _{1,

2,

3,

4,

5} , Monika Zielińska-Pisklak _{1,

2,

5,

6,

7}

Affiliation

This is a commentary on a paper by S. Aitipamula et al. (CrystEngComm, 2009, 11, 1823–1827) on the detailed analysis of the stability of trimorphic cocrystals involving two pharmaceutically active substances, ethenzamide and gentisic acid.

中文翻译：

的评论“涉及两种活性药物成分的药物共晶的Trimorphs：潜在相关组合药物”由S. Aitipamula，PS周和RBH谈，CrystEngComm，2009，11，1823 †

这是对S. Aitipamula等人的论文的评论。（CrystEngComm，2009，11，1823年至1827年）在涉及两种药物活性物质，乙柳酰胺和龙胆酸trimorphic共结晶的稳定性的详细的分析。

更新日期：2017-12-13

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>